Leibniz Institute for Immunotherapy (LIT)
The LIT is a research institute within the Leibniz Association located in Regensburg, Germany with approx. 110 staff members.
Mission
At the LIT we develop innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation. By reprogramming immune cells through synthetic and pharmacologic intervention, we build cells that save lives.
Research
Our scientific activities are structured into three Research Areas: Discovery, Translation, and Clinical Application. All three work in synergy with one another. Our work starts with basic research into the areas of immune regulation, immune metabolism, cancer, and tissue homeostasis. It carries on with a focus on therapy development—spanning the creation of new formats of genetic and pharmacologic cell manipulation and drug-compliant manufacturing processes. Finally, we seek to apply our discoveries in early clinical trials on patients themselves.
Academic Europe, the European career network for Academics, Researchers and Scientists
